Ali- Hasan- Al- Saegh Sadeq, Mirhosseini Seyed Jalil, Tahernejad Mahbube, Mahdavi Parisa, Shahidzadeh Azadeh, Karimi-Bondarabadi Ali Akbar, Dehghan Ali-Mohammad, Rahimizadeh Elham, Haddad Fatemeh, Ghodratipour Zahra, Sarrafan-Chaharsoughi Zahra, Shahidzadeh Arezoo, Ghanei Azam, Lotfaliani Mohammadreza, Zeriouh Mohamed, Weymann Alexander, Popov Aron-Frederik, Sabashnikov Anton
Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Department of Physiology, Shiraz University of Medical Sciences, Shiraz, Iran.
Cardiovasc Ther. 2016 Oct;34(5):360-70. doi: 10.1111/1755-5922.12207.
This systematic review with meta-analysis sought to determine the strength of evidence in terms of the impact of common antioxidant supplementations, such as N-acetylcysteine (NAC), vitamin C, and polyunsaturated fatty acids (PUFA) on perioperative outcomes after cardiac surgery with particular focus on the incidence of atrial fibrillation (AF) and acute kidney injury (AKI) with associated mortality. A total of 29 trials were identified that reported incidence of AF and 17 trials that reported incidence of AKI. Pooled analysis reported that NAC (OR=0.5; P=.001), vitamin C (OR=0.4; P=.001), and PUFA (OR=0.8; P=.01) administration were associated with significantly reduced incidence of AF. In terms of postoperative AKI, only NAC was shown to be a beneficial supplement that was able to significantly reduce the incidence of AKI (OR=0.7; P=.01), and NAC could also significantly decrease overall mortality (OR=0.3; P=.03) following cardiac surgery. The use of NAC in patients undergoing cardiac surgery should be strongly recommended due to its combined cardio-renal protective effects and reduced mortality. Also, PUFA and vitamin C might be able to significantly decrease the incidence of arrhythmia; however, reno-protective effects and impact on overall mortality of these supplements seem to be less impressive.
这项系统性综述及荟萃分析旨在确定常见抗氧化剂补充剂,如N-乙酰半胱氨酸(NAC)、维生素C和多不饱和脂肪酸(PUFA)对心脏手术后围手术期结局的影响的证据强度,特别关注房颤(AF)和急性肾损伤(AKI)的发生率及相关死亡率。共确定了29项报告AF发生率的试验和17项报告AKI发生率的试验。汇总分析报告称,给予NAC(比值比[OR]=0.5;P=0.001)、维生素C(OR=0.4;P=0.001)和PUFA(OR=0.8;P=0.01)与AF发生率显著降低相关。就术后AKI而言,仅NAC被证明是一种有益的补充剂,能够显著降低AKI的发生率(OR=0.7;P=0.01),并且NAC还可显著降低心脏手术后的总体死亡率(OR=0.3;P=0.03)。鉴于NAC具有心脏和肾脏保护联合作用且能降低死亡率,强烈建议在接受心脏手术的患者中使用NAC。此外,PUFA和维生素C可能能够显著降低心律失常的发生率;然而,这些补充剂的肾脏保护作用及对总体死亡率的影响似乎不太显著。